Cohort 3 for Endometriosis

"This medical study stipulates that the minimum age for eligibility is 18 and the cut-off age is 50."

"The safety of Cohort 1 was rated a 2 on our internal scale, as this is Phase 2 trial and there has only been evidence confirming the former with no reported success on efficacy."

"Affirmative. According to clinicaltrials.gov, the medical study was initially posted on September 14th 2022 and is currently in search of 75 patients from 3 separate sites. The trial was last edited on January 24th 2023."

"Affirmative, the information hosted on clinicaltrials.gov implies that this research is actively recruiting patients. It was originally published on September 14th 2022 and updated most recently on January 24th 2023. The trial requires 75 participants from 3 different sites to participate in it."

"This medical trial is searching for 75 volunteers, aged 18-50 years old and suffering from endometriosis. To be considered eligible to participate in this study one must have the capacity to provide informed consent, naturally identify as female and not pregnant at Visit 0 or 1, free of any systemic illness that may influence the tissue collection procedure; no excision/ablation procedures within a year prior to screening visit (Visit 0); suspected of having endometriosis or previously diagnosed with it and recommended laparoscopic surgery by physician; scheduled for laparoscopy 60 days after screening visit (Visit 0) after obtaining biopsy on first"